Original article by Paul Sakkal, Melissa Cunningham, Liam Mannix, Rachel Clun, Emma Koehn
The Age – Page: Online : 22-Apr-21
The Victorian government has announced that it will contribute $50m to the cost of establishing a facility to manufacture mRNA-based vaccines in Melbourne. Professor Colin Pouton of Monash University believes that this amount of funding would be sufficient to establish a facility for the local manufacturing of the COVID-19 vaccines that were developed by Pfizer and Moderna. He says Australia could begin producing these vaccines within a year, adding that this could be accelerated if CSL – which is producing AstraZeneca’s adenovirus-based vaccine – becomes involved. Australia currently receives limited supplies of the Pfizer vaccine.
MONASH UNIVERSITY, PFIZER INCORPORATED, MODERNA INCORPORATED, ASTRAZENECA PLC, CSL LIMITED – ASX CSL